Numerous studies have demonstrated that the IFN pathway is essential in autoimmune diseases, particularly in systemic lupus erythematosus and type I diabetes mellitus, by promoting T‐ and B‐cell proliferation and survival, enhancing antibody production and facilitating IG class switching.14, 57, 58, 59. The gene discussed is IFNA1; the disease is systemic lupus erythematosus.